Dr. Benedikt Asbach

Weitere Beteiligungen

• 28.03.2023

  • Poster
  • P 405

  Transgene expression knockdown in recombinant Modified Vaccinia virus Ankara vectors improves genetic stability and sustained transgene expression across passages

   Vaccines, Viral vectors and gene therapy
• 28.03.2023

  • Poster
  • P 310

  Generation and characterization of an Adenoviral vaccine candidate expressing the pentameric complex of human cytomegalovirus

   Adaptive immunity, Vaccines
• 28.03.2023

  • Poster
  • P 299

  Ex vivo characterization of IE-1/pp65-expressing adenoviral vectors as potential T cell vaccine candidates for human Cytomegalvirus

   Adaptive immunity, Vaccines
• 28.03.2023

  • Poster
  • P 114

  Neutralizing Influenza A H1N1 using functionalized DNA-origami nanoshells

   Emerging viruses and zoonosis
• 28.03.2023

  16:45 – 17:00 12 Min. 3 Min.

  • Abstract Talk
  • O 017

  Establishing a virus-free antibody binding inhibition assay using a synthetic Notch receptor

   Diagnostic methods and tools, SARS-CoV-2
• 31.03.2023

  11:15 – 11:30 12 Min. 3 Min.

  • Abstract Talk
  • O 117

  Trivalent MVA-based vaccine candidate induces a potent immune response against Sudan Ebolavirus, Marburg and Lassa fever virus in guinea pigs

   Vaccines, Viral vectors and gene therapy